Heel pain study pulled before it even started

NCT ID NCT02668510

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study aimed to test whether adding platelet-rich plasma (PRP) to shockwave therapy helps active soldiers with long-lasting plantar fasciitis more than shockwave alone. The trial was withdrawn before enrolling any participants, so no data were collected. The goal was to reduce first-step pain and improve function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

platelet rich plasma (PRP) and extracorporeal shock wave therapy

What this could lead to

If it had worked, this could have pointed toward a more effective treatment for stubborn heel pain in active people.

What could go wrong

The trial was withdrawn before enrolling anyone, so no results are available. It is unclear if PRP adds any benefit over shockwave alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FASCIITIS, PLANTAR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plantar fasciitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • William Beaumont Army Medical Center

    El Paso, Texas, 79920, United States